デフォルト表紙
市場調査レポート
商品コード
1629614

乳酸リンゲル液注射剤市場:製剤別、容量別、年齢層別、容器別、流通チャネル別、地域別

Lactated Ringers Injection Market, By Formulation, By Volume, By Age Group, By Container, By Distribution Channel, By Geography


出版日
ページ情報
英文 145 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
乳酸リンゲル液注射剤市場:製剤別、容量別、年齢層別、容器別、流通チャネル別、地域別
出版日: 2024年12月03日
発行: Coherent Market Insights
ページ情報: 英文 145 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の乳酸リンゲル注射剤市場は、2024年には5億1,010万米ドルと推定され、2024年から2031年までのCAGRは5.9%を示し、2031年には7億6,220万米ドルに達すると予測されています。

レポート範囲 レポート詳細
基準年 2023年 2024年の市場規模 5億1,010万米ドル
実績データ 2019~2023年まで 予測期間 2024~2031年まで
予測期間2024~2031年 CAGR: 5.90% 2031年の価値予測 7億6,220万米ドル
図.乳酸リンゲル液市場シェア(%)、2024年地域別
Lactated Ringers Injection Market-IMG1

乳酸リンゲル注射剤は、体液の蘇生と脱水の管理に使用される最も一般的に処方される静脈内輸液の1つです。体内の電解質バランスと体液量の回復に役立ちます。輸液療法を必要とする慢性疾患や傷害の有病率が上昇しているため、世界の乳酸リンゲル注射剤市場は、近年着実に成長しています。さらに、電解質の不均衡を起こしやすい老年人口の増加も、乳酸リンゲル注射剤の需要増加に寄与しています。世界の意識の高まりとヘルスケア施設へのアクセスの改善により、市場は予測期間中も良好な見通しを維持すると予想されます。

市場力学:

世界の乳酸リンゲル注射剤市場は、電解質の不均衡につながることが多い糖尿病、心血管疾患、腎臓病などの慢性的な健康状態の有病率の上昇に起因して、着実な成長を遂げています。さらに、交通事故、負傷、外傷のリスクが高まっており、緊急輸液による蘇生が必要なケースが増加していることが、市場の成長をさらに後押ししています。さらに、電解質障害に罹患しやすい老年人口の増加が、乳酸リンゲル注射剤の高い維持需要を生み出しています。しかし、輸液承認に関する厳しい規制が市場成長の妨げになる可能性があります。さらに、代替の点滴療法製品が入手可能であることも抑制要因となっています。一方、新興国におけるヘルスケア投資の増加は、市場参入者に大きな機会を提供しています。

本調査の主な特徴

本レポートでは、世界の乳酸リンゲル注射液市場を詳細に分析し、2023年を基準年とした予測期間(2024~2031年)の市場規模および複合年間成長率(CAGR%)を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリクスを解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の乳酸リンゲル注射液市場の主要企業をプロファイルしています。

主な企業は、Baxter International Inc.、B. Braun Melsungen AG、ICU Medical, Inc.、Fresenius Kabi AG、Hospira, Inc.、Otsuka Pharmaceutical Co., Ltd.、Dechra Pharmaceuticals PLC、Vedco, Inc.、Grifols S.A.、Pfizer Inc.、Amgen Inc.、Eton Pharmaceuticals, Inc.、Sagent Pharmaceuticals, Inc.、Aurobindo Pharma Limitedなどです。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の乳酸リンゲル注射剤市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界の乳酸リンゲル注射剤市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の乳酸リンゲル注射市場、製剤別、2019~2031年

  • 標準乳酸リンゲル液
  • 添加物(デキストロース、塩化ナトリウムなど)入り乳酸リンゲル液

第5章 世界の乳酸リンゲル注射市場、容量別、2019~2031年

  • 250ml
  • 500mL
  • 1,000ml

第6章 世界の乳酸リンゲル注射市場、年齢層別、2019~2031年

  • 成人
  • 小児
  • 高齢者

第7章 世界の乳酸リンゲル注射市場、容器別、2019~2031年

  • プラスチックボトル
  • PVCバッグ
  • ガラス瓶・小瓶など

第8章 世界の乳酸リンゲル注射市場、流通チャネル別、2019年~2031年

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 世界の乳酸リンゲル注射市場、地域別、2019~2031年

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第10章 競合情勢

  • Baxter International Inc.
  • Braun Melsungen AG
  • ICU Medical, Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols S.A.
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

第11章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第12章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7567

The global lactated ringers injection market is estimated to be valued at USD 510.1 Mn in 2024 and is expected to reach USD 762.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 510.1 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.90% 2031 Value Projection: US$ 762.2 Mn
Figure. Lactated Ringers Injection Market Share (%), By Region 2024
Lactated Ringers Injection Market - IMG1

Lactated ringers injection is one of the most commonly prescribed intravenous fluids used for fluid resuscitation and management of dehydration. It helps restore electrolyte balance and fluid volume in the body. The global lactated ringers injection market has been witnessing steady growth in the recent past due to the rising prevalence of chronic diseases and injuries that require intravenous therapy. Furthermore, the growing geriatric population who are more prone to electrolyte imbalance is also contributing to the increased demand for lactated ringers injection. With growing awareness and improved access to healthcare facilities globally, the market is expected to continue its positive outlook over the forecast period.

Market Dynamics:

The global lactated ringers injection market has been experiencing steady growth attributed to the rising prevalence of chronic health conditions such as diabetes, cardiovascular diseases, and kidney ailments that often lead to electrolyte imbalance. Additionally, the growing risk of road accidents, injuries, and trauma cases requiring emergency fluid resuscitation are further propelling market growth. Furthermore, the growing geriatric population who are more susceptible to electrolyte disorders is creating high maintenance demand for lactated ringers injection. However, stringent regulations pertaining to intravenous fluid approvals may hinder market growth. Moreover, the availability of alternative IV therapy products acts as a restraint. On the other hand, increasing healthcare investments in emerging nations provide significant opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global lactated ringers injection market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global lactated ringers injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius Kabi AG, Hospira, Inc., Otsuka Pharmaceutical Co., Ltd., Dechra Pharmaceuticals PLC, Vedco, Inc., Grifols S.A., Pfizer Inc., Amgen Inc., Eton Pharmaceuticals, Inc., Sagent Pharmaceuticals, Inc., and Aurobindo Pharma Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global lactated ringers injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lactated ringers injection market

Market Segmentation

  • By Formulation Insights (Revenue, USD Mn, 2019 - 2031)
    • Standard Lactated Ringer's Solution
    • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
  • By Volume Insights (Revenue, USD Mn, 2019 - 2031)
    • 250 ml
    • 500 ml
    • 1,000 ml
  • By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
    • Adults
    • Pediatrics
    • Geriatrics
  • By Container Insights (Revenue, USD Mn, 2019 - 2031)
    • Plastic Bottles
    • PVC Bags
    • Glass Bottles/Vials etc.
  • By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Baxter International Inc.
    • Braun Melsungen AG
    • ICU Medical, Inc.
    • Fresenius Kabi AG
    • Hospira, Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • Dechra Pharmaceuticals PLC
    • Vedco, Inc.
    • Grifols S.A.
    • Pfizer Inc.
    • Amgen Inc.
    • Eton Pharmaceuticals, Inc.
    • Sagent Pharmaceuticals, Inc.
    • Aurobindo Pharma Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lactated Ringers Injection Market, By Formulation
    • Global Lactated Ringers Injection Market, By Volume
    • Global Lactated Ringers Injection Market, By Age Group
    • Global Lactated Ringers Injection Market, By Container
    • Global Lactated Ringers Injection Market, By Distribution Channel
    • Global Lactated Ringers Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lactated Ringers Injection Market, By Formulation, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Standard Lactated Ringer's Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Lactated Ringers Injection Market, By Volume, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • 250 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 500 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 1,000 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Lactated Ringers Injection Market, By Age Group, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Lactated Ringers Injection Market, By Container, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Plastic Bottles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • PVC Bags
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Glass Bottles/Vials etc.
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Lactated Ringers Injection Market, By Distribution Channel, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Lactated Ringers Injection Market, By Region, 2019 - 2031, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ICU Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hospira, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols S.A.
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us